JP Morgan Maintains Overweight on Exelon, Lowers Price Target to $46
Portfolio Pulse from richadhand@benzinga.com
JP Morgan analyst Jeremy Tonet maintains an Overweight rating on Exelon (NASDAQ:EXC) but lowers the price target from $50 to $46.
June 07, 2023 | 1:51 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
JP Morgan maintains an Overweight rating on Exelon (NASDAQ:EXC) and lowers the price target from $50 to $46.
JP Morgan's lowered price target on Exelon may cause some short-term uncertainty among investors, but the maintained Overweight rating indicates that the analyst still believes in the stock's potential. The impact on the stock price is expected to be neutral in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100